“21. SS was initially reluctant to engage but cooperated with the support of staff. She was able to focus and maintain eye contact. There was evidence of emotional lability, predominantly irritability but I could not elicit features of depression or mania. I could not elicit any psychotic symptoms. 22. There was also no evidence of acute changes in level of alertness suggestive of an acute confusional state. 23. SS did not engage in a formal cognitive assessment but there was evidence of marked global deficits including in orientation to time and place, impairment in short-term memory and deficits in executive functioning, affecting judgement and insight. She had limited insight into her health and care needs. She denied she had any memory issues, she had limited insight relating to the extent of cognitive impairment, and of how this affected her activities of daily living and care and support needs.”
“patient appears confused and unable to fully understand. Initially agrees to have vaccination and reports will go down the road to her usual doctor and get it. Subsequently refuses the vaccination. Carer.. re explained what I had relayed to the patient and the patient has difficulty understanding the reason for the call and the vaccinations. Doesn’t appear to understand what Coronavirus is despite being explained to twice. Unable to retain any information given. Patient then declines to continue with the consultation. Patient failed capacity assessment as unable to fully understand the information given nor retain the information [SS] doesn’t have capacity to consent for Covid-19 vaccination. In the event of a best interest meeting, I would support vaccination and it would not be necessary to review the patient’s capacity at the time of administration of vaccine given that her dementia is a progressive condition since at least 2019 when it was last formally assessed.”
“I understand a court protection order is pending. I suspect if the decision is made to administer the vaccine, the administration would be challenging with this patient. Any physical restraint would need to be necessary and proportionate with the minimum amount of force for the shortest period of time. I believe restrictive physical intervention will be required in this case to protect the patient and staff from coming to harm. Clinical holding by several staff members should be sufficient for administration in this case. However, this would be a decision taken jointly with the vaccine administrator and care home staff.”
“I venture, however, to add the following observations: (i) First, P's wishes and feelings will always be a significant factor to which the court must pay close regard: see Re MM; Local Authority X v MM (by the Official Solicitor) and KM[2007] EWHC 2003 (Fam) ,[2009] 1 FLR 443 , at paras [121]-[124]. (ii) Secondly, the weight to be attached to P's wishes and feelings will always be case-specific and fact-specific. In some cases, in some situations, they may carry much, even, on occasions, preponderant, weight. In other cases, in other situations, and even where the circumstances may have some superficial similarity, they may carry very little weight. One cannot, as it were, attribute any particular a priori weight or importance to P's wishes and feelings; it all depends, it must depend, upon the individual circumstances of the particular case. And even if one is dealing with a particular individual, the weight to be attached to their wishes and feelings must depend upon the particular context; in relation to one topic P's wishes and feelings may carry great weight whilst at the same time carrying much less weight in relation to another topic. Just as the test of incapacity under the 2005 Act is, as under the common law, 'issue specific', so in a similar way the weight to be attached to P's wishes and feelings will likewise be issue specific. (iii) Thirdly, in considering the weight and importance to be attached to P's wishes and feelings the court must of course, and as required by section 4(2) of the 2005 Act, have regard to all the relevant circumstances. In this context the relevant circumstances will include, though I emphasise that they are by no means limited to, such matters as: a) the degree of P's incapacity, for the nearer to the borderline the more weight must in principle be attached to P's wishes and feelings: Re MM; Local Authority X v MM (by the Official Solicitor) and KM at para [124]; b) the strength and consistency of the views being expressed by P; c) the possible impact on P of knowledge that her wishes and feelings are not being given effect to: see again Re MM; Local Authority X v MM (by the Official Solicitor) and KM, at para [124];d) the extent to which P's wishes and feelings are, or are not, rational, sensible, responsible and pragmatically capable of sensible implementation in the particular circumstances; and e) crucially, the extent to which P's wishes and feelings, if given effect to, can properly be accommodated within the court's overall assessment of what is in her best interests.”
"(2) The person making the determination [for the purposes of this Act what is in a person's best interests] must consider all the relevant circumstances and, in particular, take the following steps. (3) He must consider—(a) whether it is likely that the person will at some time have capacity in relation to the matter in question, and (b) if it appears likely that he will, when that is likely to be. … (5) Where the determination relates to life-sustaining treatment he must not, in considering whether the treatment is in the best interests of the person concerned, be motivated by a desire to bring about his death. (6) He must consider, so far as is reasonably ascertainable—(a) the person's past and present wishes and feelings (and, in particular, any relevant written statement made by him when he had capacity), (b) the beliefs and values that would be likely to influence his decision if he had capacity, and (c) the other factors that he would be likely to consider if he were able to do so. (7) He must take into account, if it is practicable and appropriate to consult them, the views of— . . . (b) anyone engaged in caring for the person or interested in his welfare, . . .as to what would be in the person's best interests and, in particular, as to the matters mentioned in subsection (6)."
"[39] The most that can be said, therefore, is that in considering the best interests of this particular patient at this particular time, decision-makers must look at his welfare in the widest sense, not just medical but social and psychological; they must consider the nature of the medical treatment in question, what it involves and its prospects of success; they must consider what the outcome of that treatment for the patient is likely to be; they must try and put themselves in the place of the individual patient and ask what his attitude towards the treatment is or would be likely to be; and they must consult others who are looking after him or are interested in his welfare, in particular for their view of what his attitude would be." "[45] Finally, insofar as Sir Alan Ward and Arden LJ were suggesting that the test of the patient's wishes and feelings was an objective one, what the reasonable patient would think, again I respectfully disagree. The purpose of the best interests test is to consider matters from the patient's point of view. That is not to say that his wishes must prevail, any more than those of a fully capable patient must prevail. We cannot always have what we want. Nor will it always be possible to ascertain what an incapable patient's wishes are. Even if it is possible to determine what his views were in the past, they might well have changed in the light of the stresses and strains of his current predicament. In this case, the highest it could be put was, as counsel had agreed, that "
“Potential options available in a non-consenting adult such as SS: 3. I note that there has been no record of SS ever having been administered sedative medication including benzodiazepines or antipsychotics. In such a ‘neuroleptic naïve’ individual, it would be advisable to use sedative medication such as Lorazepam (0.5 mg – 1 mg) orally as a single dose approximately one hour before the proposed injection. This is an anxiolytic and sedative medication which is used across NHS trusts in management of anxiety, sleep disorder and also in management of acutely disturbed behaviour. Lorazepam is available as an oral solution. Consideration could be given to covert administration in SS’s best interests. I would not advice use of an antipsychotic medication such as Haloperidol or Olanzapine (antipsychotic medication). 4. Use of a sedative medication such as Lorazepam often leads to a reduced need for physical restraint. Physical restraint should it be required, would need to be proportionate, performed in conjunction with use of appropriate communication and de-escalation methods by experienced staff. Staff trained in behavioural management and control procedures should be deployed where possible. Staff familiar with SS should be available during the vaccine administration process so as to reassure her, de-escalate and support her in the post-vaccine administration period. The likely impact upon SS of administering the Covid-19 against her wishes using any of the available methods, and how any such risks could be minimised: 5. With vaccination, there remain some general risks including common side effects of pain in injection site, swollen lymph nodes, general malaise. of side effects, and with Astra Zeneca vaccine, rare risk of blood clots. 6. In SS’s case, due to the presence of advanced dementia, SS would be at higher risk of developing ‘Delirium’, an acute confusional state due to the vaccination. 7. It is likely that SS will manifest with irritability and possibly agitation and a degree of hostility, during the process and in the subsequent period. Staff that SS has a positive relationship and familiarity with should be available to support her during this period. She may also require continued treatment with anxiolytics for a few days following the injection. Other supportive measures such as analgesics and anti-inflammatory medications may be required for general side effects.”